An MRI Evaluation of Patients Who Underwent Treatment with a Cell-Mediated Gene Therapy for Degenerative Knee Arthritis: A Phase IIa Clinical Trial

Abstract

Multiple therapies have been developed to slow down the progression of knee osteoarthritis (OA), with the aim of avoiding or delaying TKA. One such potential method is cell-mediated gene therapy, which utilizes allogeneic human chondrocytes modified to express transforming growth factor-β1. Using magnetic resonance imaging (MRI), we evaluated patients who underwent treatment with this injection in a Phase II study and assessed structural changes in: (1) bone marrow edema lesions, (2) cartilage defect depth and surface area, (3) articular bone surface and osteophytes, and (4) meniscus structure and signal, as well as changes in (5) joint fluid, (6) periarticular inflammation, and (7) synovial inflammation. Twenty-seven patients (6 men and 21 women) who had late-stage OA were randomized 1:1 to receive a 3:1 mixture of nontransduced chondrocytes and genetically engineered chondrocytes, at doses of 6 × 10⁶ cells (group 1) or 1.8 × 10⁷ cells (group 2). MRI was performed at baseline (preinjection), and at 6 and 12 months postinjection. The whole-organ MRI score system was used to assess the aforementioned changes. Treatment was considered to be successful if patients experienced an improvement in or no change in their scores, indicating that the disease had not progressed. All patients in both cohorts individually demonstrated an improvement or no change in one or more of the assessment parameters. At 6 months, the low-dose cohort demonstrated worsening in mean scores in one parameter (bone surface and osteophytes), while the high-dose cohort demonstrated no worsening in mean scores. At 12 months, the low-dose cohort had worsening in the mean score in a subset of one parameter (cartilage signal intensity), and the high-dose cohort demonstrated worsening in mean scores in two parameters (bone surface osteophytes and periarticular inflammation). This is the first study to evaluate MRI changes in patients treated with this injection. These findings provide an impetus for further research on this topic, as well as a starting point for Phase III testing.

Keywords

MRI - cartilage regeneration - osteoarthritis - TissueGene-C

• References

• 1 Hunter DJ, Schofield D, Callander E. The individual and socioeconomic impact of osteoarthritis. Nat Rev Rheumatol 2014; 10 (07) 437-441
• 2 Waimann CA, Fernandez-Mazarambroz RJ, Cantor SB. , et al. Cost-effectiveness of total knee replacement: a prospective cohort study. Arthritis Care Res (Hoboken) 2014; 66 (04) 592-599
• 3 Waddell DD, Bricker DC. Total knee replacement delayed with Hylan G-F 20 use in patients with grade IV osteoarthritis. J Manag Care Pharm 2007; 13 (02) 113-121
• 4 Turajane T, Amphansap T, Labpiboonpong V, Maungsiri S. Total knee replacement following repeated cycles of intra-articular sodium hyaluronate (500-730 Kda) in failed conservative treatment of knee osteoarthritis: a 54-month follow-up. J Med Assoc Thai 2009; 92 (Suppl. 06) S63-S68
• 5 Evans CH, Huard J. Gene therapy approaches to regenerating the musculoskeletal system. Nat Rev Rheumatol 2015; 11 (04) 234-242
• 6 Balakrishnan B, Joshi N, Jayakrishnan A, Banerjee R. Self-crosslinked oxidized alginate/gelatin hydrogel as injectable, adhesive biomimetic scaffolds for cartilage regeneration. Acta Biomater 2014; 10 (08) 3650-3663
• 7 Somoza RA, Welter JF, Correa D, Caplan AI. Chondrogenic differentiation of mesenchymal stem cells: challenges and unfulfilled expectations. Tissue Eng Part B Rev 2014; 20 (06) 596-608
• 8 Cavallo C, Filardo G, Mariani E. , et al. Comparison of platelet-rich plasma formulations for cartilage healing: an in vitro study. J Bone Joint Surg Am 2014; 96 (05) 423-429
• 9 Mobasheri A, Kalamegam G, Musumeci G, Batt ME. Chondrocyte and mesenchymal stem cell-based therapies for cartilage repair in osteoarthritis and related orthopaedic conditions. Maturitas 2014; 78 (03) 188-198
• 10 Sun L, Reagan MR, Kaplan DL. Role of cartilage forming cells in regenerative medicine for cartilage repair. Orthop Res Rev 2010; 2010 (02) 85-94
• 11 Wang Y, Yuan M, Guo QY, Lu SB, Peng J. Mesenchymal stem cells for treating articular cartilage defects and osteoarthritis. Cell Transplant 2015; 24 (09) 1661-1678
• 12 Crawford DC, DeBerardino TM, Williams III RJ. NeoCart, an autologous cartilage tissue implant, compared with microfracture for treatment of distal femoral cartilage lesions: an FDA phase-II prospective, randomized clinical trial after two years. J Bone Joint Surg Am 2012; 94 (11) 979-989
• 13 Hunziker EB. Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. Osteoarthritis Cartilage 2002; 10 (06) 432-463
• 14 Ha CW, Noh MJ, Choi KB, Lee KH. Initial phase I safety of retrovirally transduced human chondrocytes expressing transforming growth factor-beta-1 in degenerative arthritis patients. Cytotherapy 2012; 14 (02) 247-256
• 15 Noh MJ, Copeland RO, Yi Y. , et al. Pre-clinical studies of retrovirally transduced human chondrocytes expressing transforming growth factor-beta-1 (TG-C). Cytotherapy 2010; 12 (03) 384-393
• 16 Ha CW, Cho JJ, Elmallah RK. , et al. A multicenter, single-blind, phase IIa clinical trial to evaluate the efficacy and safety of a cell-mediated gene therapy in degenerative knee arthritis patients. Hum Gene Ther Clin Dev 2015; 26 (02) 125-130
• 17 Ronga M, Angeretti G, Ferraro S, DE Falco G, Genovese EA, Cherubino P. Imaging of articular cartilage: current concepts. Joints 2014; 2 (03) 137-140
• 18 Peterfy CG, Guermazi A, Zaim S. , et al. Whole-organ magnetic resonance imaging score (WORMS) of the knee in osteoarthritis. Osteoarthritis Cartilage 2004; 12 (03) 177-190
• 19 Hassan S, Huang H, Warren K. , et al. Process change evaluation framework for allogeneic cell therapies: impact on drug development and commercialization. Regen Med 2016; 11 (03) 287-305
• 20 Anz AW, Bapat A, Murrell WD. Concepts in regenerative medicine: past, present, and future in articular cartilage treatment. J Clin Orthop Trauma 2016; 7 (03) 137-144
• 21 Christensen BB. Autologous tissue transplantations for osteochondral repair. Dan Med J 2016; 63 (04) B5236
• 22 Tan TE, Peh GS, George BL. , et al. A cost-minimization analysis of tissue-engineered constructs for corneal endothelial transplantation. PLoS One 2014; 9 (06) e100563
• 23 Jia L, Chen J, Wang Y, Liu Y, Zhang Y, Chen W. Magnetic resonance imaging of osteophytic, chondral, and subchondral structures in a surgically-induced osteoarthritis rabbit model. PLoS One 2014; 9 (12) e113707
• 24 Crema MD, Nevitt MC, Guermazi A. , et al. Progression of cartilage damage and meniscal pathology over 30 months is associated with an increase in radiographic tibiofemoral joint space narrowing in persons with knee OA--the MOST study. Osteoarthritis Cartilage 2014; 22 (10) 1743-1747
• 25 Sanghvi D, Munshi M, Pardiwala D. Imaging of cartilage repair procedures. Indian J Radiol Imaging 2014; 24 (03) 249-253